Cabozantinib enhances the efficacy and immune modulatory activity of anti-PD1 therapy in a syngeneic mouse model of hepatocellular carcinoma

被引：0
|
作者：
Esteban-Fabro, Roger [1 ]
Willoughby, Catherine E. [1 ]
Pique-Gili, Marta [1 ]
Peix, Judit [1 ]
Montironi, Carla [1 ]
Abril-Fornaguera, Jordi [1 ]
Torrens, Laura [1 ]
Pinyol, Roser [1 ]
Llovet, Josep M. [1 ,2 ,3 ]
机构：
[1] Liver Canc Translat Res Lab, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Liver Unit, Barcelona, Spain
[2] Icahn Sch Med Mt Sinai, Mt Sinai Liver Canc Program, Tisch Canc Inst, New York, NY USA
[3] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
AS053
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [31] Anti-PD1 monotherapy in hepatocellular carcinoma: a step forward or already behind?
    Catanese, Silvia
    Lordick, Florian
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (24)
  • [32] TUSC2 Enhances Sensitivity to Anti-PD1 in Kras Mutant Syngeneic Mouse Lung Cancer Through NK Cells
    Meraz, I. M.
    Majidi, M.
    Cao, X.
    Lin, H.
    Li, L.
    Wang, Jing
    Baladandayuthapani, V.
    Rice, D.
    Sepesi, B.
    Ji, L.
    Roth, J. A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (08) : S1537 - S1537
  • [33] Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy
    Sun, Guangshun
    Liu, Hanyuan
    Zhao, Jie
    Zhang, Jinyu
    Huang, Tian
    Sun, Guoqiang
    Zhao, Siqi
    Zhang, Zihao
    Cao, Hengsong
    Rong, Dawei
    Kong, Xiangyi
    Ji, Qinghua
    Liu, Li
    Wang, Xuehao
    Tang, Weiwei
    Xia, Yongxiang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (12)
  • [34] Tumor suppressor TUSC2 immunogene therapy is synergistic with anti-PD1 in lung cancer syngeneic mouse models
    Meraz, Ismail M.
    Majidi, Mourad
    Shao, RuPing
    Feng, Meng
    Cao, Xiaobo
    Rice, David
    Sepesi, Boris
    Ji, Lin
    Roth, Jack
    CANCER RESEARCH, 2017, 77
  • [35] Multi-Epitope DNA Vaccine Targeting Cancer Neoantigens Enhances Efficacy of Anti-PD1 Therapy
    Bhojnagarwala, Pratik S.
    MOLECULAR THERAPY, 2023, 31 (04) : 677 - 678
  • [36] MULTI-EPITOPE DNA VACCINE TARGETING CANCER NEOANTIGENS ENHANCES EFFICACY OF ANTI-PD1 THERAPY
    Bhojnagarwala, Pratik
    Perales-Puchalt, Alfredo
    Gary, Ebony
    Sardesai, Niranjan
    Weiner, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1217 - A1217
  • [37] Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody
    Kanaya, Nobuhiko
    Kuroda, Shinji
    Kakiuchi, Yoshihiko
    Kumon, Kento
    Tsumura, Tomoko
    Hashimoto, Masashi
    Morihiro, Toshiaki
    Kubota, Tetsushi
    Aoyama, Katsuyuki
    Kikuchi, Satoru
    Nishizaki, Masahiko
    Kagawa, Shunsuke
    Tazawa, Hiroshi
    Mizuguchi, Hiroyuki
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    MOLECULAR THERAPY, 2020, 28 (03) : 794 - 804
  • [38] Proton beam radiotherapy combined with anti-PD1/PDL1 immune checkpoint inhibitors for advanced hepatocellular carcinoma
    Su, Chung-Wei
    Hou, Ming-Mo
    Huang, Pei-Wei
    Chou, Yung-Chih
    Huang, Bing-Shen
    Tseng, Jeng-Hwei
    Hsu, Chao-Wei
    Chang, Tung-Chieh
    Lin, Shi-Ming
    Lin, Chen-Chun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (04): : 1606 - +
  • [39] β-hydroxy-β-methylbutyrate enhances anti-PD1 immunotherapy in a mouse model of pancreatic ductal adenocarcinoma.
    Etigunta, Suhas K.
    Coleman, Michael F.
    Pfeil, Alex J.
    Lashinger, Laura M.
    Cui, Zhengrong
    Hursting, Stephen D.
    CANCER RESEARCH, 2021, 81 (13)
  • [40] Therapeutic Effects of Anti-PD1 Immunotherapy on Hepatocellular Carcinoma Under Administration of Tacrolimus
    Hsu, Yu-Chen
    Chen, Chien-Hung
    Huang, Hui-Fu
    Lee, Ying-Te
    Wu, Meng-Chuan
    Su, Chien-Wen
    Chou, Huei-Chi
    Wang, Li-Fang
    Lee, Hsuan-Shu
    Lin, Shu-Wha
    Hsu, Ping-Ning
    Wu, Yao-Ming
    Sheu, Jin-Chuan
    Weng, Meng-Tzu
    TRANSPLANTATION, 2023, 107 (07) : 1492 - 1501
12345